New pill targets Tough-to-Treat cancers in brain and lungs
NCT ID NCT05256290
Summary
This study is testing an oral medication called BDTX-1535 for adults with advanced non-small cell lung cancer or glioblastoma (a type of brain tumor) that have specific genetic changes. The goal is to find the safest and most effective dose and see if the drug can shrink tumors, especially those that have spread to the brain. Participants will take the pill daily in 21-day cycles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
City of Hope Huntington Beach
Huntington Beach, California, 92648, United States
-
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California, 92618, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Fred Hutchinson Cancer Center/University of Washington
Seattle, Washington, 98109, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Mayo Clinic- Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic- Rochester
Rochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
Miami Cancer Institute - Baptist Health South Florida
Miami, Florida, 33176, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Next Ocology
Fairfax, Virginia, 22031, United States
-
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, 60611, United States
-
Sibley Memorial Hospital Johns Hopkins Medicine
Washington D.C., District of Columbia, 20016, United States
-
Siteman Cancer Center
St Louis, Missouri, 63110, United States
-
Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UHP- University of Hawaii Cancer Center
Honolulu, Hawaii, 96813, United States
-
UNC Hospitals - Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27514, United States
-
University of Alabama
Birmingham, Alabama, 35294, United States
-
University of Kansas Cancer Center
Fairway, Kansas, 66205, United States
-
University of Pittsburgh Medical Center - Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.